These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical study of patients with Alzheimer's disease under treatment with tacrine]. García-López MT; Guardado-Santervás P Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762 [No Abstract] [Full Text] [Related]
6. Alzheimer's and Cognex. Steel JG N C Med J; 1995 Feb; 56(2):72-3. PubMed ID: 7741935 [No Abstract] [Full Text] [Related]
7. [Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease]. Estadieu MC; Machou C; Berthezène P; Pastor MJ; Angelini B; Bohor M; Bongrand MC; Timon-David P; Gastaut JL; Allain H; Michel BF Therapie; 1998; 53(1):67-76. PubMed ID: 9773102 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: the role of tacrine therapy. Jogerst G Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656 [No Abstract] [Full Text] [Related]
9. [Tacrine in Alzheimer's disease]. López de Munain A Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671 [No Abstract] [Full Text] [Related]
10. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset]. Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154 [TBL] [Abstract][Full Text] [Related]
11. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
12. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease. Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977 [No Abstract] [Full Text] [Related]
13. Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study. Gutzmann H; Kühl KP; Hadler D; Rapp MA Pharmacopsychiatry; 2002 Jan; 35(1):12-8. PubMed ID: 11819153 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study. Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903 [TBL] [Abstract][Full Text] [Related]